$2.27
0.083.65%
At close: -
$2.19
-0.08-3.52%
After Hours: Dec 19, 5:20 PM EDT
Comments
Loading...
Genelux (NASDAQ:GNLX) Stock Quotes, Forecast and News Summary
Genelux Stock (NASDAQ: GNLX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Genelux (GNLX) stock?
You can purchase shares of Genelux (NASDAQ:GNLX) through any online brokerage.
Who are Genelux (GNLX) competitors?
Other companies in Genelux’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Armata Pharmaceuticals (AMEX:ARMP), Citius Oncology (NASDAQ:CTOR), Inovio Pharmaceuticals (NASDAQ:INO) and OS Therapies (AMEX:OSTX).
What is the forecast, or price target, for Genelux (GNLX) stock?
Genelux has a consensus price target of $23.00.
What is the current price for Genelux (GNLX)?
The stock price for Genelux (NASDAQ: GNLX) is $2.19 last updated December 19, 2024 at 5:20 PM EST.
Does Genelux (GNLX) pay a dividend?
There are no upcoming dividends for Genelux.
When is Genelux (NASDAQ:GNLX) reporting earnings?
Genelux’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Genelux (GNLX) going to split?
There is no upcoming split for Genelux.
What sector and industry does Genelux (GNLX) operate in?
Genelux is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.